Abstract Title:

Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma.

Abstract Source:

Leuk Lymphoma. 2015 Jul 1:1-27. Epub 2015 Jul 1. PMID: 26133723

Abstract Author(s):

Ommoleila Molavi, Nasser Samadi, Chengsheng Wu, Afsaneh Lavasanifar, Raymond Lai

Article Affiliation:

Ommoleila Molavi


Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), an oncogenic fusion protein carrying constitutively active tyrosine kinase, is known to be central to the pathogenesis of ALK-positive anaplastic large cell lymphoma (ALK(+)ALCL). Here, we report that silibinin, a non-toxic naturally-occurring compound, potently suppressed NPM-ALK and effectively inhibited the growth and soft agar colony formation of ALK(+)ALCL cells. By western blots, we found that silibinin efficiently suppressed the phosphorylation/activation of NPM-ALK and its key substrates/downstream mediators (including STAT3, MEK/ERK, and Akt) in a time- and dose-dependent manner. Correlating with these observations, silibinin suppressed the expression of Bcl-2, survivin and JunB, all of which are found to be upregulated by NPM-ALK and pathogenetically important in ALK(+)ALCL. Lastly, silibinin augmented the chemosensitivity of ALK(+)ALCL cells to doxorubicin, particularly the small cell subset expressing the transcriptional activity of Sox2, an embryonic stem cell marker. To conclude, our findings suggest that silibinin might be useful in treating ALK(+)ALCL.

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.